CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-05 | Sherman Jeffrey Scott Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +249,169 | 249,169 | ||
| 2022-12-01 | Stone Warren President, Clinical Services | Grant or award | +89,206 | 89,206 | ||
| 2022-12-01 | Stone Warren President, Clinical Services | Grant or award · Stock Option (Right to Buy) | +166,113 | 166,113 | ||
| 2022-11-03 | Perez David Brian Director | Grant or award | +10,300 | 10,300 | ||
| 2022-11-03 | Perez David Brian Director | Grant or award · Stock Option (Right to Buy) | +9,730 | 9,730 | ||
| 2022-11-01 | Dieter Cynthia J Chief Accounting Officer | Grant or award | +13,141 | 31,721 | ||
| 2022-08-15 | Smith Christopher M Chief Executive Officer | Grant or award | +336,767 | 336,767 | ||
| 2022-08-15 | Smith Christopher M Chief Executive Officer | Grant or award | +265,452 | 602,219 | ||
| 2022-08-15 | Smith Christopher M Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +694,444 | 694,444 | ||
| 2022-08-01 | Sholehvar David President, Clinical Services | Grant or award | +12,352 | 43,216 | ||
| 2022-08-01 | Sholehvar David President, Clinical Services | Grant or award · Stock Option (Right to Buy) | +25,826 | 25,826 | ||
| 2022-08-01 | Kulkarni Shashikant President of Lab Operations | Grant or award | +24,704 | 65,856 | ||
| 2022-08-01 | Kulkarni Shashikant President of Lab Operations | Grant or award · Stock Option (Right to Buy) | +51,653 | 51,653 | ||
| 2022-06-22 | Dieter Cynthia J Chief Accounting Officer | Shares withheld for taxes | −57 | 18,580 | ||
| 2022-06-10 | Kelly Michael Aaron Director | Grant or award | +15,556 | 20,419 | ||
| 2022-06-10 | Kelly Michael Aaron Director | Grant or award · Stock Option (Right to Buy) | +13,882 | 13,882 | ||
| 2022-06-10 | KANOVSKY STEPHEN M Director | Grant or award | +15,556 | 24,754 | ||
| 2022-06-10 | KANOVSKY STEPHEN M Director | Grant or award · Stock Options (Right to Buy) | +13,882 | 13,882 | ||
| 2022-06-10 | CROWTHER BRUCE K Director | Grant or award | +15,556 | 65,120 | ||
| 2022-06-10 | CROWTHER BRUCE K Director | Grant or award · Stock Option (Right to Buy) | +13,882 | 13,882 |
Page 19 of 23 · 447 trades